News Smoking Appears Linked to Brain Abnormalities in People with MS-related Disease, Study Suggests Smoking Appears Linked to Brain Abnormalities in People with MS-related Disease, Study Suggests by Patricia Inacio, PhD | April 8, 2016 Share this article: Share article via email Copy article link A team of researchers suggested that cigarette smoking is associated with adverse effects to white matter in the brain, and reported that smoking may underlie the clinical course of clinically isolated syndrome, an early and potentially predictive symptom of a progression to multiple sclerosis (MS). The study, “Influence of cigarette smoking on white matter in patients with clinically isolated syndrome as detected by diffusion tensor imaging,” was published in the Diagnostic and Interventional Radiology journal. Cigarette smoking is one of the environmental risk factors associated with increased occurrence of MS, even in passive smokers, together with worsening clinical disability and faster disease progression. Clinically isolated syndrome is an inflammatory demyelinating disorder of the central nervous system, and the first clinical episode predicting the possible occurrence of MS. MS, a disabling disease of the central nervous system, is characterized by damage to the myelin coating around nerve fibers, which disrupts transmission of nerve signals between the brain, spinal cord, and the rest of the body. Researchers investigated the effects of smoking on white matter in patients with clinically isolated syndrome using diffusion tensor imaging, a technique that allows evaluating white matters’ tissue integrity. To this end, the team analyzed smoking patients with clinically isolated syndrome (n=16), healthy controls who smoke (n=13), nonsmoking patients with clinically isolated syndrome (n=17), and nonsmoking healthy controls (n=14). All patients fulfilled the McDonald diagnostic criteria for MS, but registered only one clinical episode involving optic neuritis, cervical and/or thoracic myelitis, or brainstem/cerebellar syndrome. The team scanned 13 regions of interest (including nonenhancing T1 hypointense lesion and perilesional white matter), and 11 normal-appearing white matter regions. Researchers found a tendency for greater lesion load in smoking patients. When compared to healthy smokers, smokers with clinically isolated syndrome showed more, and more extensive, normal-appearing white matter changes, denoted by increased mean diffusivity. However, no relationship was found between diffusion metrics and clinical disability scores, duration of the disease, and degree of smoking exposure. In conclusion, results suggested that patients who smoke may have a tendency toward a greater number of white matter lesions, and exhibit significantly more extensive normal-appearing white matter abnormalities, as detected by diffusion tensor imaging. Print This Page About the Author Patricia Inacio, PhD Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship. Tags clinically isolated syndrome, white matter lesions
April 19, 2024 News by Lindsey Shapiro, PhD AAN 2024: Long-term data support early Kesimpta start in relapsing MS
April 18, 2024 Columns by Benjamin Hofmeister Learning how to write a ‘SOAP’ note feels different after an MS diagnosis
April 18, 2024 News by Marisa Wexler, MS AAN 2024: Sustained myelin, nerve cell gains with long-term CNM-Au8